Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.
Epistemonikos ID: d246e9be9c5b235e93206fdd08414c24cec38ee4
First added on: Sep 03, 2026